1H-Indene-3-aceticacid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)-

CAS : 38194-50-2

Ref. IN-DA007B4T

Informations sur le produit

• Nom: 1H-Indene-3-aceticacid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)-
• Synonymes: [u'Aclin', u'Apo Sulin', u'Apo-Sulin', u'Arthrobid', u'Arthrocine', u'Chibret', u'Clinoril', u'Copal', u'Kenalin', u'Klinoril', u'MK 231', u'MK-231', u'MK231', u'Novo Sundac', u'Novo-Sundac', u'Nu Sulindac', u'Nu-Sulindac', u'Sulindac', u'Sulindal', u'sulindac', u'Clinoril', u'Arthrocine', u'38194-50-2', u'Sulindac sulfoxide', u'Sulindaco', u'Sulindacum', u'Mobilin', u'MK 231', u'Sulindacum [INN-Latin]', u'Sulindaco [INN-Spanish]', u'Aflodac', u'Sulreuma', u'C20H17FO3S', u'CCRIS 3305', u'CHEBI:9352', u'(Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid', u'cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid', u'(Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid', u'cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid', u'EINECS 253-819-2', u'BRN 2951842', u'Algocetil', u'Artribid', u'Citireuma', u'Clisundac', u'Imbaral', u'Reumofil', u'Sulinol', u'CHEMBL15770', u'Sudac', u'1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-, (Z)-', u'NCGC00015970-02', u'Arthrobid', u'Klinoril', u'CAS-38194-50-2', u'DSSTox_CID_3624', u'2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid', u'DSSTox_RID_77117', u'DSSTox_GSID_23624', u'(S)-Sulindac', u'cis-Sulindac', u'Sulindac (Clinoril)', u'2-[(1Z)-5-fluoro-1-[(4-methanesulfinylphenyl)methylidene]-2-methyl-1H-inden-3-yl]acetic acid', u'Clinoril (TN)', u'Sulindac [USAN:BAN:INN:JAN]', u'{(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid', u'SR-01000075237', u'Moblilin', u'(Z)-2-[5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl]acetic Acid', u'2-(5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylene}inden-3-yl)acetic acid', u'32004-68-5', u'EINECS 250-893-8', u'EINECS 256-402-3', u'Sulindac [USAN:USP:INN:BAN:JAN]', u'Tocris-1707', u'AC1LU7GY', u'Clinoril;Aflodac;Sulreuma', u'Prestwick3_000073', u'Spectrum5_001024', u'Lopac-S-8139', u'S 8139', u'Sulindac, >=98.0%', u'SCHEMBL4202', u'SCHEMBL4203', u'5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid', u'Lopac0_001070', u'BSPBio_000285', u'BSPBio_002890', u'MLS001056554', u'SPECTRUM1500556', u'Sulindac (JP17/USP/INN)', u'BPBio1_000315', u'GTPL5425', u'DTXSID4023624', u'CHEBI:93811', u'HMS501O03', u'cMAP_000021', u'MLKXDPUZXIRXEP-MFOYZWKCSA-N', u'HMS1921C11', u'HMS2092K15', u'HMS2095O07', u'HMS2231N24', u'HMS3259K06', u'HMS3263E22', u'HMS3649P19', u'HMS3678N09', u'HMS3712O07', u'Pharmakon1600-01500556', u'HY-B0008', u'Tox21_110270', u'Tox21_301418', u'Tox21_501070', u'BDBM50012899', u'BDBM50103504', u'CCG-39264', u'NSC757344', u's2007', u'SBB058181', u'AKOS015895412', u'cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidenyl)indene-3-acetic acid', u'Tox21_110270_1', u'CS-0569', u'DB00605', u'KS-5153', u'LP01070', u'NC00540', u'NSC-757344', u'(Z)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid', u'(Z)-5-Fluoro-2-methyl-1-[[4-(methyl-sulfinyl)phenyl]methylene]-1H-indene-3-acetic acid', u'1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)-'], (1Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid, (Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid, (Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid, 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-, (Z)-, 1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)-, 5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid, Aflodac, Algocetil, Arthrocine, Artribid, Brn 2951842, Ccris 3305, Citireuma, Clinoril, Clisundac, Imbaral, Mk 231, Mobilin, Reumofil, Reumyl, Sudac, Sulindac sulfoxide, Sulindaco, Sulindacum, Sulinol, Sulreuma, Unii-184Sns8Vuh, cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid, cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid, cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidenyl)indene-3-acetic acid, cis-Sulindac, {(1E)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid, {5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid
• Marque: Indagoo

Propriétés chimiques

• Masse moléculaire: 356.4106
• Formule: C₂₀H₁₇FO₃S
• Degré de pureté: 98%
• Couleur/Forme: Solid
• InChI: InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-
• Code InChI: MLKXDPUZXIRXEP-MFOYZWKCSA-N